Tuesday, January 04, 2022
Remedy Entertainment has announced that it has signed a “global development, license, and distribution agreement” with Chinese entertainment conglomerate Tencent, for its upcoming title Vanguard.
First revealed during a Remedy financial report nearly two years ago, Vanguard is set to be a free-to-play co-operative PvE shooter, and is due to release on consoles and PC. Remedy says that it aims to combine the studio's “narrative expertise and action gameplay” with an immersive multiplayer experience, with Remedy set to publish the game worldwide, except in certain Asian markets, where Tencent will instead localise and publish the game.
“Vanguard marks Remedy’s first entry into Games-as-a-Service business model, executed by our top tier team of free-to-play experts. We are building something new and exciting for co-operative multiplayer space, on top of Remedy’s strengths,” says Remedy CEO Tero Virtala. “Expanding our capabilities to take on publishing responsibilities is the next step in the development of our company. We are excited for this long-term partnership with Tencent and with confidence can say that it is an excellent fit in supporting Vanguard’s ambitious plans. Vanguard is a global opportunity, and Tencent can support Remedy internationally, and lead the operations in Asia and the mobile markets.”
Vanguard is currently in the “proof-of-concept phase” according to Remedy, with its development budget (including one year of post-launch operations) currently sitting around the same size as a normal Remedy AAA title. As part of the deal, Tencent will also be given the rights to develop and publish a mobile version of Vanguard.
We've got little more information to go on regarding Vanguard, but we do know it won't be built in Remedy's Northlight Engine, unlike the studio's other upcoming co-op PvE game, Condor, which is due to be a multiplayer spin-off from Control.
If you're worried about Remedy moving into the multiplayer space, don't fret - the developer is also working on Alan Wake 2, which is due to be Remedy's first proper survival horror title.
Tuesday, January 04, 2022 @ 08:14 AM
Tuesday, January 04, 2022 @ 10:59 AM
Tuesday, January 04, 2022 @ 01:21 PM
Tuesday, January 04, 2022 @ 05:52 PM